Respiratory syncytial virus (RSV) (Fig ... Different modes of transmission are possible, with the most recurrent being through inoculation of the nasopharyngeal or conjunctival mucosa with ...

There was a significant drop in the number of babies hospitalized with RSV this year; a positive news story that can be ...

In adults, the two most common were influenza and RSV (respiratory syncytial virus), while ... while unwell should reduce the risk of transmission. The virus is a distant cousin of RSV for which ...

A 2024-25 flu season that has been classified as high severity has now reached low transmission levels, but 10 new ...

01. A committee of independent vaccine experts voted Wednesday to recommend lowering the age at which adults can get a vaccine against respiratory syncytial virus, potentially opening up access to ...

The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.

In a recent study of a population of infants, published online May 6 in Pediatrics, 72% of infants were found to be immunized against respiratory syncytial virus (RSV). Nirsevimab administration ...

Background: Toys in pediatric office waiting rooms may be fomites for transmission of viruses ... January samples were tested for respiratory syncytial virus and March samples were tested for ...

Enanta’s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting ...

Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in hospitalized infants under six months of age with respiratory syncytial virus.

HHS and the National Institutes of Health plan to develop universal vaccines targeting a broad range of flu and coronavirus strains using a new whole-virus platform. The platform, dubbed Generation ...